An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis-Reference-Cited by-同舟云学术

An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis

Author:

Atiq Omair¹,Tiro Jasmin²³,Yopp Adam C.⁴,Muffler Adam¹,Marrero Jorge A.¹,Parikh Neehar D.⁴,Murphy Caitlin³,McCallister Katharine³,Singal Amit G.¹²³

Affiliation:

1. Department of Internal Medicine; UT Southwestern Medical Center and Parkland Health Hospital System; Dallas TX

2. Harold C. Simmons Cancer Center; UT Southwestern Medical Center; Dallas TX

3. Department of Clinical Sciences; UT Southwestern Medical Center; Dallas TX

4. Department of Surgery; UT Southwestern Medical Center, Dallas, TX; and Department of Medicine, University of Michigan; Ann Arbor MI

Funder

AHRQ Center for Patient-Centered Outcomes Research

Publisher

Wiley

Subject

Hepatology

Link

Reference35 articles.

3. management of hepatocellular carcinoma: an update;Bruix;Hepatology,2010

4. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer;J Hepatol,2012

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献